Internal Medicine, Transplant Hepatology · Cincinnati, OH
NPI
1295099703
Since 2012
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
222 Piedmont Ave
Cincinnati, OH, 45219
Phone (513) 475-7505
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
506 services
Medicare patients, 2024
236
Average age 68
Drug cost, 2024
$503K
1,631 prescriptions
Company payments, 2025
$71.72
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amoah Yeboah-Korang was code 99215 (office e&m - established), 126 times for 83 patients. In total Amoah Yeboah-Korang billed 506 services in 27 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 126 | 83 | $95.74 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 82 | 31 | $86.01 | $7,053 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 48 | 43 | $11.97 | $575 |
| 99214 Office E&M - Established | Office | 33 | 24 | $82.66 | $2,728 |
| 99214 Office E&M - Established | Facility | 31 | 26 | $59.98 | $1,859 |
| 99223 Hospital E&M - Initial | Facility | 25 | 24 | $122.85 | $3,071 |
| 99215 Office E&M - Established | Office | 22 | 14 | $121.99 | $2,684 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 12 | $59.16 | $1,124 |
| 45385 Colonoscopy - Lesion Removal | Facility | 16 | 16 | $188.35 | $3,014 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.91 | $181 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $98.46 | $1,378 |
| 43239 Upper GI Endoscopy | Facility | 11 | 11 | $76.27 | $839 |
By year: 2022 $33K for 327 services; 2023 $38K for 382 services; 2024 $42K for 506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amoah Yeboah-Korang prescribed most often to Medicare patients was Mycophenolate Mofetil, with 260 prescriptions and refills. In total Amoah Yeboah-Korang wrote 1,631 Medicare prescriptions that cost $503K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mycophenolate Mofetil Generic | 260 | 456 | 57 | $22K |
| Tacrolimus Generic | 234 | 453 | 48 | $24K |
| Entecavir Generic | 88 | 155 | 19 | $10K |
| Carvedilol Generic | 76 | 174 | 26 | $384 |
| Ursodiol Generic | 59 | 90 | 13 | $6,241 |
| Pantoprazole Sodium Generic | 57 | 129 | 22 | $319 |
| Everolimus Generic | 57 | 57 | Under 11 | $109K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 57 | 57 | 55 | $800 |
| Spironolactone Generic | 53 | 100 | 17 | $913 |
| Furosemide Generic | 51 | 109 | 18 | $205 |
| Azathioprine Generic | 40 | 75 | Under 11 | $13K |
| Xifaxan Rifaximin | 33 | 43 | Under 11 | $137K |
| Omeprazole Generic | 33 | 78 | 12 | $405 |
| Gabapentin Generic | 32 | 57 | Under 11 | $301 |
| Cyclosporine Modified Cyclosporine, Modified | 31 | 35 | Under 11 | $2,869 |
Brand drugs: - claims; generic drugs: 1,505 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amoah Yeboah-Korang $71.72 ($71.72 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $23.78.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.